Novo Nordisk, Transocean, Walgreen, Adamas and Novo Nordisk are big market movers

NEW YORK, N.Y. – Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:


Novo Nordisk AS, up 95 cents to $43.67

U.S. regulators approved the pharmaceutical company’s diabetes drug to be used to treat obesity, the first injectable cleared for weight loss.

Walgreen Co., up 16 cents to $76.67

Wall Street is ecstatic over the numbers from the drug store’s latest quarter, with many analysts upping their price targets on the stock.

Brookfield Residential Properties Inc., up $1.15 to $24.01

Brookfield Asset Management is buying the slice of the land developer it does not own after upping its offer by more than 5 per cent.

Transocean Ltd., down 37 cents to $18.77

Crude prices that stabilized this week after months of declines slumped again and dragged big energy companies down with them.


Taser International Inc., 85 cents to $26.87

Major orders continue to roll in for the maker of defence equipment used by police departments, particularly its body cameras.

GoPro Inc., up $4.87 to $66.41

Wall Street has been down on the adventure camera maker but Wedbush says consumers love it and major retailers are selling out.

Virgin America Inc., up $5.19 to $41

Analysts have tried to single out which airlines will win big with oil prices dropping, and Virgin is the latest favourite.

Adamas Pharmaceuticals Inc., $1.45 to $16.10

A new application for Namzaric from the drugmaker and partner Actavis was approved by the FDA for Alzheimer’s-type dementia.